Clinical Trials Logo

Safety Issues clinical trials

View clinical trials related to Safety Issues.

Filter by:

NCT ID: NCT04207710 Completed - Pain Clinical Trials

Safety of Gebauer's Pain Ease and Gebauer's Ethyl Chloride

Start date: January 26, 2021
Phase: Phase 4
Study type: Interventional

This study aims to determine if Gebauer's Pain Ease or Gebauer's Ethyl Chloride topical anesthetic sprays are safe for use as numbing agents prior to placing epidurals and arterial lines, based on whether they introduce increased microbial growth after application to skin. Due to the recent national shortage of lidocaine, we hope to find a suitable alternative to lidocaine for topical analgesia when placing arterial lines and epidurals. Our hypothesis is that the sprays will not affect the sterility of the area. We will compare microbial growth from three subsequent swabs taken from a single area of skin on the wrist and lower back: one with no treatment, the second after treatment with ChloraPrep, and the third after applying one of the numbing sprays. If there is significantly higher growth in the swabs containing the topical anesthetic spray versus the ChloraPrep alone, this will indicate that the sprays introduce microbes to the sites of skin.

NCT ID: NCT04196335 Completed - Safety Issues Clinical Trials

I Can sEe Left Atrial Appendage (ICELAA) Clinical Study

ICELAA
Start date: July 29, 2020
Phase: N/A
Study type: Interventional

The primary objective of this study is to assess the efficacy and safety of using intra-procedural intracardiac echocardiography (ICE) for WATCHMAN FLX Device implants in subjects with non-valvular atrial fibrillation to reduce the risk of stroke.

NCT ID: NCT04188821 Completed - Quality of Life Clinical Trials

Reduction of Seroma and Improvement of QoL in Breast Reconstruction With Tissue Expander

Start date: September 1, 2016
Phase: N/A
Study type: Interventional

The experimental hypothesis of this randomized controlled study was to demonstrate that early drain removal in patients who underwent immediate breast reconstruction with tissue expander is a safety procedure to improving clinical outcomes and quality of life (QoL). The mechanism of action underlying the proposed approach was intuitive. The early drain removal allows to: 1) avoid continuous seroma development caused by active suction of drain (stopping the circle "drain itself may perpetuate the drainage" with vacuum mechanism); 2) reduce the risks connected to "foreign body reaction" as tissue inflammation and infection; 3) improve QoL reducing pain, length of hospital stay and limitations of daily activities.

NCT ID: NCT04174586 Recruiting - Safety Issues Clinical Trials

Cord Blood Microtransplantation for Treatment of Acute Myeloid Leukemia

Start date: January 22, 2020
Phase: Phase 1
Study type: Interventional

Discuss the effectiveness and safety of cord blood microtransplantation for treatment of acute myeloid leukemia

NCT ID: NCT04169685 Recruiting - Safety Issues Clinical Trials

Dexmedetomidine for Sedation Undergoing Bronchoscopy

Start date: April 1, 2017
Phase:
Study type: Observational

Several sedatives or analgesics can be used to achieve appropriate levels of sedation for endoscopic procedures. Dexmedetomide is notable for providing sedation without respiratory depression. We hypothesized dexmedetomide is more suitable for sedation of bronchoscopy than other sedative drugs.

NCT ID: NCT04161677 Completed - Safety Issues Clinical Trials

MIST3: Active Patient Safety Reporting

MIST3
Start date: November 21, 2019
Phase:
Study type: Observational

This study will seek to describe and understand adverse events (AE) severity ratings.

NCT ID: NCT04140604 Completed - Safety Issues Clinical Trials

Safety Evaluation of Lactobacillus Salivarius AP-32 and Bifidobacterium Animalis Subsp. Lactis CP-9 in Healthy Infants.

Start date: February 11, 2020
Phase: N/A
Study type: Interventional

This is a three-arm, double-blind, placebo-controlled study to investigate the safety of Lactobacillus salivarius AP-32 and Bifidobacterium animalis subsp. lactis CP-9 used individually in healthy infants. Infants will be given the content of one capsule (mixed in infant formula or breast milk) twice daily (morning and evening) for 15 weeks.

NCT ID: NCT04113343 Completed - Safety Issues Clinical Trials

Oral Remimazolam With and Without Alcohol in Healthy Female Subjects

Start date: May 30, 2017
Phase: Phase 1
Study type: Interventional

A Phase 1 Study to Determine the Single-dose Pharmacodynamics, Pharmacokinetics, and Safety and Tolerability of Remimazolam Following Oral Administration With and Without Alcohol in Healthy Female Subjects

NCT ID: NCT04100642 Completed - Safety Issues Clinical Trials

A Phase I Clinical Study of Hemay808

Start date: April 8, 2019
Phase: Phase 1
Study type: Interventional

This is a first-in-human study in health volunteers. The purpose is the local tolerability and systemic safety of Hemay808, which is an ointment made of a novel small molecule Hemay028. The safety and systemic pharmacokinetics (PK) of Hemay028 will be evaluated following topical application of Hemay808 to healthy volunteers.

NCT ID: NCT04057833 Active, not recruiting - Safety Issues Clinical Trials

E-CEL UVEC Cells as an Adjunct Cell Therapy for the Arthroscopic Rotator Cuff Repair in Adults

Start date: November 20, 2019
Phase: Phase 1
Study type: Interventional

This is a phase 1b investigator-initiated clinical trial that will evaluate the safety and feasibility of E-CEL UVEC® cells with the aim of improving outcomes for patients with full-thickness rotator cuff tears who undergo arthroscopic surgical repair. Allogeneic E-CEL UVEC cells will be delivered to the tendon repair site and to the muscle adjacent to the tendon repair site.